![]() |
市場調查報告書
商品編碼
1374833
全球氣管切開插管市場 - 2023-2030Global Tracheostomy Tube Market - 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
氣管造口術是一種外科手術,涉及在頸部切開一個切口,將一根管子插入氣管,即所謂的氣管造口管。氣管造口管是一種人工氣道,透過手術透過喉嚨的開口直接放入氣管。它繞過上呼吸道作為建立呼吸連結的手段。氣管切開插管有利於正壓通氣,允許清除分泌物,並為上呼吸道阻塞的患者提供通暢的氣道。
當通常的呼吸路線因某種原因被阻塞或減少時,氣管造口術提供了一條有助於呼吸的空氣通道。當健康問題需要長期使用機器(呼吸器)來幫助呼吸時,通常需要氣管切開插管。在極少數情況下,當氣道突然阻塞時,例如臉部或頸部外傷後,會進行緊急氣管切開術。當不再需要氣管切開術時,可以使其癒合閉合或透過手術閉合。對某些人來說,氣管切開術是永久性的。
氣管切開插管的不斷進步預計將在預測期內推動市場發展。這些管子的進步有助於為患者提供多種選擇,讓患者根據自己的選擇進行選擇。先進的氣管切開插管的設計通常優先考慮患者的舒適度。更柔軟的材料、減少刺激和符合人體工學的設計等特點有助於提高患者的耐受性和依從性,從而提高氣管造口插管的接受度。
例如,2020 年 1 月,全球醫療器材製造商 Smiths Medical 在其氣管切開插管系列中推出了新的聚氯乙烯 (PVC) 氣管切開插管產品組合。在照顧氣管造口患者時,應選擇最適合患者特定臨床需求的插管。新型氣管切開插管為各種患者提供了多種選擇。
此外,技術創新旨在解決與氣管造口管相關的常見併發症,例如感染、肉芽腫形成和氣管狹窄。透過最大限度地減少這些風險,先進的氣管切開插管提高了手術的安全性,鼓勵患者在需要時選擇這種干涉措施。氣喘等氣道疾病的增加增加了對氣管切開插管的需求。
例如,根據 CDC 的 2020 年全國健康訪問調查 (NHIS),估計美國有 2,520 萬成年人,其中包括 420 萬名兒童患有氣喘。 2020 年,超過 1,030 萬名氣喘患者(包括約 180 萬名兒童)報告曾出現過一次或多次氣喘發作。因此,對於出現急性呼吸窘迫的氣喘患者,首選經口氣管插管。因此,從上述表述來看,市場預期將帶動市場成長。
此外,材料和設計的進步導致氣管切開插管的功能得到改善。這包括整合抽吸系統、用於更好密封的袖帶和聲門下抽吸等功能,所有這些都有助於更好的呼吸支援和管理。一些先進的氣管切開插管提供客製化選項,以滿足個別患者的獨特需求。
此外,氣道疾病的盛行率不斷增加、臨床試驗的增加、對插管的認知不斷提高以及具有先進功能的技術先進插管的開發是預計在預測期內推動市場的因素。
與插管相關的併發症和風險等因素,如感染、縱膈氣腫、喉部或氣管損傷、氣管切開插管阻塞、意外拔管、氣管軟化、氣管食道瘺、氣管狹窄和出血、缺乏熟練的專業人員以及高昂的費用預計管材的數量將阻礙市場。
A tracheostomy is a surgical procedure involving making an incision in the neck to insert a tube into the trachea, which is known as a tracheostomy tube. A tracheostomy tube is an artificial airway that is surgically placed directly into the trachea through an opening in the throat. It bypasses the upper airway as a means to establish a connection for breathing. Tracheostomy tubes facilitate positive pressure ventilation, allow for access for secretion removal, and provide a patent airway for patients with obstructed upper airways.
A tracheostomy provides an air passage that helps to breathe when the usual route for breathing is somehow blocked or reduced. A tracheostomy tube is often needed when health problems require long-term use of a machine (ventilator) to help breathe. In rare cases, an emergency tracheotomy is performed when the airway is suddenly blocked, such as after a traumatic injury to the face or neck. When a tracheostomy is no longer needed, it's allowed to heal shut or is surgically closed. For some people, a tracheostomy is permanent.
The increasing advancements in tracheostomy tubes is expected to drive the market over the forecast period. The advancements in these tubes helps to provide a wide range of options for patients to choose according to the patients choice. Advanced tracheostomy tubes often come with designs that prioritize patient comfort. Features such as softer materials, reduced irritation, and ergonomic designs contribute to improved patient tolerance and compliance, leading to increased acceptance of tracheostomy tubes.
For instance, in January 2020, Smiths Medical, a global medical device manufacturer, has launched a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio to its family of tracheostomy tubes. When caring for a patient with a tracheostomy, a tube should be chosen to best suit the patient's specific clinical need. The new tracheostomy tubes have options for a variety of patients.
Moreover, technological innovations aim to address common complications associated with tracheostomy tubes, such as infections, granuloma formation, and tracheal stenosis. By minimizing these risks, advanced tracheostomy tubes enhance the safety profile of the procedure, encouraging patients to opt for this intervention when needed. The increasing airway disorders such as asthma are increasing the demand for tracheostomy tubes.
For instance, according to the CDC's 2020 National Health Interview Surveys (NHIS), an estimated 25.2 million adults, including 4.2 million children, have asthma in the United States. In 2020, more than 10.3 million asthmatics, including approximately 1.8 million children, reported having one or more asthma attacks. Therefore, orotracheal intubation is preferred for asthmatic patients in acute respiratory distress. Thus, from the above statements, the market is expected to drive market growth.
Additionally, advancements in materials and design led to tracheostomy tubes with improved functionality. This includes features like integrated suction systems, cuffs for better sealing, and subglottic suctioning, all of which contribute to better respiratory support and management. Some advanced tracheostomy tubes offer customization options to meet the unique needs of individual patients.
Further, the increasing prevalence of airway disorders, increasing clinical trials, increasing awareness about the tubes and development of technologically advanced tubes with advanced features are the factors expected to drive the market over the forecast period.
Factors such as complications and risks associated with the tubes such as infection, pneumomediastinum, damage to the larynx or trachea, obstruction in the tracheostomy tube, accidental decannulation, tracheomalacia, tracheoesophageal fistula, tracheal stenosis and bleeding, lack of skilled professionals and the high cost of the tubes are expected to hamper the market.
The global tracheostomy tube market is segmented based on type, component, material, end-user and region.
The polyvinyl chloride (PVC) tubes segment is expected to hold the largest market share over the forecast period. PVC softens at body temperature, conforming to patient anatomy and centering the tube in the trachea. PVC is generally considered biocompatible, meaning it is well-tolerated by the human body. This is a crucial characteristic of materials used in the tracheostomy tubes.
Moreover, PVC tubes are also known for their flexibility, which is essential for medical tubing applications. They can be easily shaped and molded to suit the specific requirements of tracheostomy tubes. PVC is also durable and resistant to breakage, which offers wide advantages for patients using tracheostomy tubes. PVC tubes are often transparent, allows to visually inspect fluids passing through the tube. This transparency is advantageous for monitoring and assessing the patient's condition.
Furthermore, PVC can be easily sterilized, making it suitable for maintaining sterility. PVC is a cost-effective material, which is an important consideration for tracheostomy tubes. PVC is resistant to many chemicals, which is beneficial for applications where the tube may come into contact with various fluids and medications. Thus, owing to the above factors, the segment is expected to largest market share.
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of tracheostomy tubes. North America especially the United States is home to many major players such as medical device companies manufacturing tracheostomy tubes. These companies often have well-established and extensive research and development capabilities and a strong market presence. The presence of major players actively performing in clinical trials, leads to the advancements in the tracheostomy tubes.
In addition, the region is also known for the increasing adoption of tracheostomy tubes for various airway applications. The aging population and the prevalence of respiratory conditions contribute to the growing adoption of tracheostomy tubes in the region. As the population ages, there is an increased likelihood of respiratory issues, necessitating interventions such as tracheostomy procedures by using tracheostomy tubes. The increasing adoption leads to the development of advanced tubes.
For instance, on June 21, 2023, Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, revealed a global recall of affected batches of the below-mentioned Rusch Endotracheal Tube products. The Rusch Endotracheal Tube devices are indicated for oral or nasal intubation for airway management via insertion into a patient's tracheal via nose or mouth. Stylets are used to aid the insertion of endotracheal tubes into the trachea.
The major global players in the tracheostomy tube market include: Teleflex Incorporated, Medtronic plc, Healthcare 21 Ltd, Advin Health Care, Gcmedica Enterprise Ltd., Global Medikit Limited, Angiplast Pvt Ltd., Coloplast Group, Boston Medical Products Inc. and TRACOE medical GmbH among others.
The COVID-19 pandemic significantly impacted the global tracheostomy tube market. COVID-19 primarily affects the respiratory system, and severe cases often require intensive respiratory support. This increased the demand for ventilators and other devices including tracheostomy tubes, to assist in the management of critically ill patients.
The pandemic created unprecedented challenges to the market by temporarily disrupting many clinical trials and research activities due to the redirected focus on the COVID-19 pandemic. The pandemic also disrupted the supply chain of devices globally.
The global tracheostomy tube market report would provide approximately 69 tables, 78 figures, and 189 Pages.
LIST NOT EXHAUSTIVE